Hemab Therapeutics Holdings, Inc. Common Stock enterprise value

The Enterprise Value as of October 2026 (TTM) for Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is 1.37B

According to Hemab Therapeutics Holdings, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 1.37B. This represents a change of 17.98% compared to the average of 1.16B of the last 4 quarters.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Historical Enterprise Value (quarterly & annually)

How has COAG Enterprise Value performed in the past?

The mean historical Enterprise Value of Hemab Therapeutics Holdings, Inc. Common Stock over the last ten years is 846.30M. The current 1.37B Enterprise Value has changed 61.95% with respect to the historical average. Over the past ten years (40 quarters), COAG's Enterprise Value was at its highest in in the March 2026 quarter at 1.45B. The Enterprise Value was at its lowest in in the June 2026 quarter at 869.64M.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hemab Therapeutics Holdings, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Average Enterprise Value

How has COAG Enterprise Value performed in the past?

The current Enterprise Value of Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) Enterprise Value vs. Peers

How is COAG’s Enterprise Value compared to its peers?

Hemab Therapeutics Holdings, Inc. Common Stock’s Enterprise Value is greater than Damora Therapeutics, Inc. (761.49M), less than Disc Medicine, Inc. (2.82B), greater than Rallybio Corporation (-4447669.00), greater than uniQure N.V. (1.21B),

Build a custom stock screener for Hemab Therapeutics Holdings, Inc. Common Stock (COAG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemab Therapeutics Holdings, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hemab Therapeutics Holdings, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.